Substituted Benzofurans, Benzothiophenes, Benzoselenophenes and Indoles and Their Use as Tubulin Polymerisation Inhibitors
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/AU2007/000101, filed Feb 2, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,346,842 | Substituted Benzofurans, Benzothiophenes, Benzoselenophenes and Indoles and Their Use as Tubulin Polymerisation Inhibitors In force · High confidence | Bionomics Limited | In force | High confidence | ||
| US 10,213,409 | Substituted Benzofurans, Benzothiophenes, Benzoselenophenes and Indoles and Their Use as Tubulin Polymerisation Inhibitors In force · Low confidence | Bionomics Limited | In force | Low confidence | ||
| US 8,198,466 | Substituted Benzofurans, Benzothiophenes, Benzoselenophenes and Indoles and Their Use as Tubulin Polymerisation Inhibitors In force · High confidence | Bionomics Limited | In force | High confidence | ||
| US 8,680,135 | Substituted Benzofurans, Benzothiophenes, Benzoselenophenes and Indoles and Their Use as Tubulin Polymerisation Inhibitors Lapsed Mar 25, 2026 on the fee record Ended Mar 25, 2026 · High confidence | Bionomics Limited | Lapsed Mar 25, 2026 on the fee record | Ended Mar 25, 2026 | High confidence |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Bionomics Limited.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.